Cargando…
Evaluation of genetic and phenotypic consistency of Bacillus coagulans MTCC 5856: a commercial probiotic strain
Commercial probiotics preparation containing Bacillus coagulans have been sold in the market for several decades. Due to its high intra-species genomic diversity, it is very likely that B. coagulans strain may alter in different ways over multiple years of production. Therefore, the present study fo...
Autores principales: | Majeed, Muhammed, Nagabhushanam, Kalyanam, Natarajan, Sankaran, Sivakumar, Arumugam, Eshuis-de Ruiter, Talitha, Booij-Veurink, Janine, de Vries, Ynte P., Ali, Furqan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4771827/ https://www.ncbi.nlm.nih.gov/pubmed/26925622 http://dx.doi.org/10.1007/s11274-016-2027-2 |
Ejemplares similares
-
Galactomannan from Trigonella foenum‐graecum L. seed: Prebiotic application and its fermentation by the probiotic Bacillus coagulans strain MTCC 5856
por: Majeed, Muhammed, et al.
Publicado: (2018) -
Bacillus coagulans MTCC 5856 supplementation in the management of diarrhea predominant Irritable Bowel Syndrome: a double blind randomized placebo controlled pilot clinical study
por: Majeed, Muhammed, et al.
Publicado: (2016) -
Bacillus coagulans MTCC 5856 for the management of major depression with irritable bowel syndrome: a randomised, double-blind, placebo controlled, multi-centre, pilot clinical study
por: Majeed, Muhammed, et al.
Publicado: (2018) -
The effects of Bacillus coagulans MTCC 5856 on functional gas and bloating in adults: A randomized, double-blind, placebo-controlled study
por: Majeed, Muhammed, et al.
Publicado: (2023) -
Probiotic modulation of gut microbiota by Bacillus coagulans MTCC 5856 in healthy subjects: A randomized, double-blind, placebo-control study
por: Majeed, Muhammed, et al.
Publicado: (2023)